Novo sued for working with Teva to delay generic Victoza
A class action lawsuit was filed in New York federal court on Friday accusing Novo Nordisk (NVO) of running a...
Tag: TEVA
Teva Pharmaceutical sees 2025 EPS at higher range of outlook
Teva Pharmaceutical Industries (TEVA) said that it anticipates its 2025 diluted EPS will be at the higher end of its...
Royalty Pharma promises $500M to Teva for advancing vitiligo treatment
Teva Pharmaceutical (TEVA) Industries and Royalty Pharma (RPRX) announced a $500M funding agreement to accelerate...
Alvotech, Teva reach settlement with Regeneron over Eylea biosimilar AVT06 in U.S.
Alvotech (ALVO) and Teva Pharmaceuticals (TEVA) have reached a settlement and license agreement with Regeneron...
Sagimet rises as licensing deal with Teva unit targets Madrigal drug
Shares of Sagimet Biosciences (SGMT) climbed on Wednesday after the company reached a license agreement with a subsidiary of...
Immuneering to be added to the Nasdaq Biotechnology Index
Immuneering Corporation (IMRX) said on Tuesday it expects to be added to the Nasdaq Biotechnology Index, effective prior to...
Teva seeks removal of over 200 patents from FDA Orange Book after FTC challenge
The Federal Trade Commission announced on Wednesday that Teva Pharmaceutical (TEVA), under pressure from the agency, has...
Mark Cuban calls for end to generic drug application fees to boost domestic manufacturing
Mark Cuban, the billionaire businessman and founder of the online discount pharmacy Cost Plus Drugs, is urging the Trump...
Teva outlines path to $2.5B AUSTEDO revenue in 2027 as innovative portfolio grows 33%
Earnings Call Insights: Teva Pharmaceutical Industries Limited (TEVA) Q3 2025 CEO Richard Francis highlighted the company's...
Earnings Snapshot: Teva Pharmaceutical Industries tops Q3 estimates; updates FY outlook above forecast
Teva Vs. Viatris: Who Will Dominate In President Trump's America? Teva Pharmaceutical: Turnaround Driven By Huge...